Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children
- Protection against pertussis by immunisation. McKendrick, M.W.; Gully, P.R.; Geddes, A.M. // British Medical Journal;11/22/1980, Vol. 281 Issue 6252, p1390
Examines the efficacy of pertussis immunization for the protection against Bordetella pertussis infection. Severity of the illness in infants; Epidemiology of pertussis; Protection against the complication of the disease.
- Neonatal BoÄŸmaca: Vaka Sunumu. Kayiran, Sinan Mahir; Gürakan, Berkan // Journal of the Child / Cocuk Dergisi;Dec2010, Vol. 10 Issue 4, p207
Pertussis is a highly contagious respiratory system infection of Bordetella pertussis which can be prevented with an immunization protocol. Although it can be seen in all age groups, the disease pursues a more severe course resulting in hospital stay and mortality in infants under 6 months and...
- Diagnosis and management of pertussis. Tozzi, Alberto E.; Celentano, Lucia Pastore; Atti, Marta Luisa Ciofi degli; Salmaso, Stefania // CMAJ: Canadian Medical Association Journal;2/15/2005, Vol. 172 Issue 4, p509
PERTUSSIS IS INCREASING IN FREQUENCY among children too young to be vaccinated and among adolescents and adults. This increase is due mainly to waning immunity among vaccinated individuals, who become susceptible during adolescence and adulthood and maintain the circulation of Bordetella...
- Children with pertussis inform the investigation of other pertussis cases among contacts. Baptista, Paulo N.; Magalhães, Vera S.; Rodrigues, Laura C // BMC Pediatrics;2007, Vol. 7, p21
Background: The number of reported pertussis has increased in the last two decades. However, many cases of pertussis may be underreported or not diagnosed. The World Health Organization estimates that pertussis causes 200.000 - 400.000 deaths each year, most deaths are in infants and in...
- Manifestations of Pertussis in Immunized Children and Adults. Kirchner, Jeffrey T. // American Family Physician;11/1/1999, Vol. 60 Issue 7, p2148
Provides information on the prevalence and incidence of Bordetella pertussis (B. pertussis) infections in adults. Clinical presentation and course of B. pertussis infection among immunized persons; Diagnosis and treatment of B. pertussis infection.
- Whooping cough vaccine `should be replaced'. Brown, Phyllida // New Scientist;10/23/93, Vol. 140 Issue 1896, p7
Reports on the use of acellular vaccines as replacement for whooping cough vaccine or pertussis. Existing whole-cell vaccine based on a suspension of the whole, killed bacterium, Bordetella pertussis; Limitations of the United States Food and Drug Administration-licensed acellular vaccine.
- Reactions after pertussis vaccine: a manufacturer's experiences and difficulties since 1964. Griffith, A.H. // British Medical Journal;4/1/1978, Vol. 1 Issue 6116, p809
Pertussis vaccines vary in quality, safety, and efficacy according to the production strains of Bordetella pertussis, the method of manufacture, and quality control procedures. It is therefore not justifiable to combine information on the incidence, nature, and severity of reactions after all...
- Editorial Commentary: Accounting for Pertussis. DeMaria, Alfred // Clinical Infectious Diseases;Jun2012, Vol. 54 Issue 12, p1736
An introduction is presented in which the editor discusses the article on pertussis vaccines.
- Immunity to the respiratory pathogen Bordetella pertussis. Higgs, R; Higgins, S C; Ross, P J; Mills, K H G // Mucosal Immunology (1933-0219);Sep2012, Vol. 5 Issue 5, p485
Bordetella pertussis causes whooping cough, a severe respiratory tract infection in infants and children, and also infects adults. Studies in murine models have shown that innate immune mechanisms involving dendritic cells, macrophages, neutrophils, natural killer cells, and antimicrobial...